Nottingham Galway - National University of Ireland, Galway

More documents

Recommendations

Info

Dr Graham Ball Graham Ball Dr Joseph Ragaz Joseph Ragaz 16 Dr Graham Ball is a reader in bioinformatics at the Nottingham Trent University. He has been involved in the development and validation of bioinformatic algorithms using Artificial Neural Networks for the last 16 years. He is currently bioinformatics lead for 2 sixth framework projects one Strep (ENACT) and one Network of Excellence (BIOPATTERN) He is a UK representative for the DTI led UK- US biosciences partnerships focusing on cancer and infectious diseases. He was a UK representative for the United Nations working group on trans-boundary air pollution effects. He currently supervises a team comprising 5 members focusing on bioinformatic analysis of a range of domains. His current research interests are directed at the application of computational bioinformatic techniques for the identification and validation of biomarkers that facilitate classification and characterisation of biological systems and populations. This is achieved through development of platform technologies centered on artificial neural network and other machine learning technologies that are applied to biological data (including proteomic, immunological and gene array sources). These platform technologies have been applied to the characterisation of patterns in microbial pathogen and cancer patient populations. Dr Joseph Ragaz, is presently Professor of Medicine and Oncology at the McGill University, Montreal, Canada. He graduated from the Westminster Medical School, London, U.K., did Internal Medicine at McGill University, Montréal, and Oncology Program at the Princess Margaret Hospital, Toronto, Canada. Subsequently, he spent 27 years (1977 - 2003) as a senior Medical Oncologist at the British Columbia Cancer Control Agency in Vancouver, where he became internationally recognized as a breast cancer researcher. Joseph's contributions include the start of Neoadjuvant Breast cancer initiatives in North America (1978 -1990) ; start of Medical adrenalectomy with Aromatase inhibitors in BC & Canada (1978 - 1983) ; and completion of the first randomized trial of radiation in Breast cancer (1984 – 2005). He was a part of the Initial BCCA team starting in North America the Breast Cancer research with Tissue microarrays (2000-2003) and was a collaborator in multiple British Columbia and Canadian Breast cancer Clinical research projects. He is also a senior committee member and contributor towards the Oxford-based Early Breast Cancer Trialist’s Collaborative Group (EBCTCG), and author of multiple peer-review manuscripts, book chapters, abstracts and books.
Professor Nigel Bundred Nigel Bundred Mr Hugh Bishop Hugh Bishop Professor of Surgical Oncology and Consultant Surgeon at the University Hospital of South Manchester and Christie Hospital, Manchester. He has research interests in preinvasive cancer (ductal carcinoma in situ), breast cancer chemoprevention and innovations in service delivery. His research in Manchester was recognised by the Royal College of Surgeons of England when he was appointed a Hunterian Professorship in 1995. Professor Bundred has a large clinical commitment in the Manchester Breast Centre, the largest breast unit in the United Kingdom. He is a member of several medical societies and has been awarded numerous honours including a Patey Prize and Ronald Raven Award. Professor Bundred has authored or coauthored over 160 peer-reviewed articles and his work has appeared in many journals, including the Journal of the National Cancer Institute, The Lancet, Cancer Research and Cancer. He is Chief Investigator on several clinical trials both nationally and internationally and he has published extensively on adjuvant therapy for breast cancer. Hugh Bishop qualified at the University of London (the Middlesex Hospital) in 1970. He trained as a General Surgeon in Birmingham, Derby and Oxford. He was a Research Fellow to Roger Blamey in Nottingham, and wrote a thesis on oestrogen receptors in the 70s. Subsequently, a consultant at the George Eliot Hospital in Nuneaton, and thereafter at the Royal Bolton Hospital. Closely involved in the production of the Association of Breast Surgery guidelines in terms of the management of symptomatic breast cancer, bone metastases and, more recently, the ABS Guidance on Oncoplastic Surgical Practice. Initiated the ABS/NHS Breast Surgical Audit. Initially, this was a shambles but, thanks to the West Midlands Cancer Intelligence Unit, has become one of the most powerful audits of surgical screening activity in the world. From this he developed the Sloane Project, an audit of non-invasive screen detected breast cancer. He was President of the Association of Breast Surgery in 2005-2007. 17
Page 1 and 2: Nottingham Galway & INTERNATIONAL B
Page 3 and 4: Contents 2 Invitation from Professo
Page 5: Introduction from Professor Roger B
Page 8 and 9: Thursday, 18th June 2009 6 8.30 Reg
Page 10 and 11: Friday, 19th June 2009 8 9.00 Regis
Page 13 and 14: Participants NUI Galway
Page 15 and 16: Professor Gordan Wishart Gordan Wis
Page 17: Ms Carmel Malone Carmel Malone Mr K
Page 21 and 22: Professor Mike Dixon Mike Dixon Mr
Page 23 and 24: Professor Carlos Caldas Carlos Cald
Page 25 and 26: Professor Carsten Rose Carsten Rose
Page 27 and 28: Mr Martin O’Sullivan Martin O’
Page 29 and 30: Professor Tom Gorey Tom Gorey Dr Ai
Page 31 and 32: Professor Robert Mansel Robert Mans
Page 33 and 34: Mr Denis Evoy Denis Evoy Dr Valerie
Page 35 and 36: Continuing Professional Development
Page 37 and 38: ✃ The Docks Galway
Page 39 and 40: The Claddagh Galway

Nottingham Galway - National University of Ireland, Galway

Create successful ePaper yourself

Delete template?

Save as template?